Avid Bioservices Inc (CDMO)
8.25
+0.05
(+0.61%)
USD |
NASDAQ |
May 03, 16:00
8.23
-0.02
(-0.24%)
After-Hours: 20:00
Avid Bioservices Total Liabilities (Quarterly): 275.06M for Jan. 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 275.06M |
| October 31, 2023 | 270.97M |
| July 31, 2023 | 251.74M |
| April 30, 2023 | 261.58M |
| January 31, 2023 | 265.04M |
| October 31, 2022 | 260.66M |
| July 31, 2022 | 272.22M |
| April 30, 2022 | 255.32M |
| January 31, 2022 | 257.52M |
| October 31, 2021 | 250.52M |
| July 31, 2021 | 225.90M |
| April 30, 2021 | 187.77M |
| January 31, 2021 | 82.81M |
| October 31, 2020 | 64.21M |
| July 31, 2020 | 59.02M |
| April 30, 2020 | 65.72M |
| January 31, 2020 | 58.14M |
| October 31, 2019 | 56.07M |
| July 31, 2019 | 52.39M |
| April 30, 2019 | 25.33M |
| January 31, 2019 | 23.05M |
| October 31, 2018 | 25.43M |
| July 31, 2018 | 27.96M |
| April 30, 2018 | 40.02M |
| January 31, 2018 | 38.34M |
| Date | Value |
|---|---|
| October 31, 2017 | 35.72M |
| July 31, 2017 | 44.27M |
| April 30, 2017 | 64.53M |
| January 31, 2017 | 71.30M |
| October 31, 2016 | 67.76M |
| July 31, 2016 | 64.67M |
| April 30, 2016 | 58.97M |
| January 31, 2016 | 59.12M |
| October 31, 2015 | 43.43M |
| July 31, 2015 | 36.59M |
| April 30, 2015 | 38.43M |
| January 31, 2015 | 29.33M |
| October 31, 2014 | 22.66M |
| July 31, 2014 | 22.02M |
| April 30, 2014 | 22.85M |
| January 31, 2014 | 21.41M |
| October 31, 2013 | 19.46M |
| July 31, 2013 | 20.78M |
| April 30, 2013 | 21.30M |
| January 31, 2013 | 19.76M |
| October 31, 2012 | 23.86M |
| July 31, 2012 | 27.58M |
| April 30, 2012 | 18.78M |
| January 31, 2012 | 16.54M |
| October 31, 2011 | 14.78M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
52.39M
Minimum
Jul 2019
275.06M
Maximum
Jan 2024
182.77M
Average
250.52M
Median
Oct 2021
Total Liabilities (Quarterly) Benchmarks
| Emergent BioSolutions Inc | 1.174B |
| Creative Medical Technology Holdings Inc | 0.3714M |
| Viking Therapeutics Inc | 33.63M |
| Stereotaxis Inc | 19.99M |
| MAIA Biotechnology Inc | 7.089M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 455.23M |
| Shareholders Equity (Quarterly) | 180.17M |
| Debt to Equity Ratio | 0.7849 |
| Current Ratio | 0.4648 |
| Net Debt Paydown Yield | -0.06% |